levodopa has been researched along with propranolol in 124 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 78 (62.90) | 18.7374 |
| 1990's | 19 (15.32) | 18.2507 |
| 2000's | 12 (9.68) | 29.6817 |
| 2010's | 15 (12.10) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jolivette, LJ; Ward, KW | 1 |
| Baert, B; Beetens, J; Bodé, S; De Spiegeleer, B; Deconinck, E; Lambert, J; Slegers, G; Slodicka, M; Stoppie, P; Van Gele, M; Vander Heyden, Y | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Giralt, E; Malakoutikhah, M; Teixidó, M | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Campillo, NE; Guerra, A; Páez, JA | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Avdeef, A; Tam, KY | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
| Barber, S; Dew, TP; Farrell, TL; Poquet, L; Williamson, G | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Shahani, BT; Young, RR | 1 |
| Agnoli, A; Carolei, A; Casacchia, M; Fazio, C; Zamponi, A | 1 |
| Bailey, PT; George, DT | 1 |
| Itoh, M | 1 |
| Gershon, S; Hine, B; Wallach, MB | 1 |
| Howe, C; Vollrath, L | 1 |
| Cramer, H; Kiessling, M; Lindl, T | 1 |
| Garcy, AM; Marotta, SF; Sithichoke, N; Yu, M | 1 |
| Cramer, H; Kiessling, M | 1 |
| Furuta, Y; Hashimoto, K; Washizaki, M | 1 |
| Fogelholm, R; Kotilainen, P; Lamberg, BA; Linnoila, M; Olkinuora, M; Saarinen, P | 1 |
| Belmaker, RH; Berman, M; Biederman, J; Ebstein, RP; Stern, R; van Praag, HM | 1 |
| Reus, VI | 1 |
| Gateau, G; Meinel, R; Strudel, G | 1 |
| Altmiller, DH; Blackett, PR; Cagas, CR; Seely, JR | 1 |
| Fass, B; Kaplan, SA; Lippe, BM | 1 |
| Blair, ML; Ganong, WF; Keil, LC; Reid, IA | 1 |
| Dadkar, VN; Dahanukar, SA; Sheth, UK | 1 |
| Moore, DC; Paunier, L; Sizonenko, PC | 1 |
| Bhatnagar, AS; Board, JA; Fierro, RJ; Wasserman, AJ | 1 |
| Barbarine, A; De Marinis, L; Troncone, L | 1 |
| Brun, G; Collu, R; Ducharme, JR; Leboeuf, G; Letarte, J; Milsant, F | 1 |
| Altszuler, N; Hampshire, J; Moraru, E | 1 |
| Deakin, JF; Green, AR | 1 |
| McKinney, AS | 1 |
| Cryer, PE; Daughaday, WH | 1 |
| Kelley, VC; Rowe, DW; Sare, Z | 1 |
| Hara, I; Itatsu, T; Itoh, M; Nihei, N; Yamauchi, K | 1 |
| Schaub, C | 1 |
| Bevan, P; Bradshaw, CM; Szabadi, E | 1 |
| Augier, D; Dutau, G; Enjaume, P; Ribot, C; Rochiccioli, P | 1 |
| Cooper, RL; Linnoila, M | 1 |
| Bergen, D; Goetz, C; Klawans, HL | 1 |
| Keichian, AH; Oliver, RE; Rivera, VM | 1 |
| Camanni, F; Isaia, GC; Massara, F; Molinatti, GM | 1 |
| Aranguren, LV; Cabezas-Cerrato, J; Fernández-Cruz, A; Mur, AL; Vila, T | 1 |
| Silfverskiöld, B | 1 |
| Bhaskar, EA; Bhaskar, PA; Jagannathan, K | 1 |
| Maclaren, NK; Raiti, S; Taylor, GE | 1 |
| Cardinali, DP; Freire, F; Nagle, CA; Rosner, JM | 1 |
| Campisi, R; Carducci Artenisio, A; Melluso, K; Ragonese, F | 1 |
| Fukushima, N | 1 |
| Antonaccio, MJ; Kerwin, L | 1 |
| Boechat, MI; Fine, RN; Lippe, BH; Moulten, L; Nelson, PA; Yadin, O | 1 |
| Lizogub, VG; Piatak, OA; Yanovskii, GV | 1 |
| Goshima, Y; Misu, Y; Nakamura, S; Ohno, K | 1 |
| Christison, GW; Kirch, DG; Wyatt, RJ | 1 |
| Coates, A; Crock, P; Palayew, K; Pianosi, P; Schiffrin, A; Weitzner, G | 1 |
| Goshima, Y; Misu, Y; Nakamura, S | 2 |
| Petkova, M; Protich, M; Tsanev, A | 1 |
| Luchins, DJ; Meltzer, HY; Sommers, AA | 1 |
| Brocki, Z; Grajek, S; Kmiecik-Kaźmierczak, E; Nikisch, B; Pyda, M | 1 |
| Grzywa, M | 1 |
| Dahlem, ST; Furlanetto, RW; Moshang, T; Wiener, DE | 1 |
| Herbster, G; Koller, WC | 1 |
| Goshima, Y; Kubo, T; Misu, Y | 1 |
| Evans, WS; Ho, KY; Thorner, MO | 1 |
| Koller, WC; Rubino, FA | 1 |
| Delitala, G; Lotti, G; Masala, A | 1 |
| Marsden, CD | 1 |
| Fawcett, CP; Krulich, L; McCann, SM; Ojeda, SR | 1 |
| George, DT; Rayfield, EJ | 1 |
| Anton, AH; Goldberg, LI; Tjandramaga, TB; Toda, N | 1 |
| Camanni, F; Massara, F; Molinatti, GM | 1 |
| De la Fuente, E; Souvatzoglou, A; von Werder, K | 1 |
| Mine, S | 1 |
| Chekodanova, NV; Chekunova, MP; Minkina, NA; Suvorov, IM; Zenkevich, ES | 1 |
| Feigenbaum, JJ; Fishman, RH; Klawans, HL; Yanai, J | 1 |
| Arkhipenko, VI; Cherkashina, LP; Sukmanskiĭ, OI | 1 |
| Kurako, IuL; Volianskiĭ, VE | 1 |
| Bekhtereva, EP | 1 |
| Cardinali, DP; Luchelli de Fortis, A; Stefano, FJ; Vacas, MI | 1 |
| Cabezas-Cerrato, J; Casanueva, FF; Peñalva, A; Villanueva, L | 1 |
| Barontini, M; Bazán, MC; Bergadá, C; Domené, H; Heinrich, JJ | 1 |
| Gamaniel, K; Osuide, G; Wambebe, C | 1 |
| Goetz, CG; Klawans, HL; Tanner, CM | 1 |
| Babayan, EA; Barkov, NK; Machula, AI | 1 |
| Frisch, H; Schober, E; Stransky, E | 1 |
| Carrillo Domínguez, A; Diéguez López, C; Mendoza Betancor, B; Rodríguez Doreste, OL; Valerón Martel, C | 1 |
| Matsumiya, T; Oka, T; Watanabe, Y | 1 |
| Barrett, JD; Sambhi, MP; Sowers, JR | 1 |
| Geffner, ME; Itami, RM; Kaplan, SA; Lippe, BM | 1 |
| Green, OC; Pelsor, DA; Winter, RJ | 1 |
| Gök, F; Gökçay, E; Gül, D; Sayli, BS | 1 |
| Kwan, E; Lim, YJ; Low, LC | 1 |
| Fix, JA; Leppert, PS | 1 |
| abo Bakr, AM; al Herbish, AS; al Jarallah, A; al Jurayyan, NA; al Rasheed, SA; Mahdi, AH | 1 |
| Enjaume, C; Oliver, I; Pienkowski, C; Rochiccioli, P; Tauber, MT | 1 |
| Dickerman, Z; Guyda, H; Tannenbaum, GS | 1 |
| Byth, K; Einstein, R; Henderson, JM; Jackson, DM; Morris, JG | 1 |
| Felice, KJ; Grunnet, ML | 1 |
| Agid, Y; Bonnet, AM; Carpentier, AF; Vidailhet, M | 1 |
| Bakke, SJ; Nyberg-Hansen, R; Shepherd, GM; Tauböll, E | 1 |
| Byth, K; Einstein, R; Henderson, JM; Jackson, D; Morris, JG; Yiannikas, C | 1 |
| Ahlskog, JE | 1 |
| Grimm, W; Koffler, T; Philippi, H; Pohlenz, J; Schönberger, W | 1 |
| Rajput, A; Rajput, AH; Robinson, CA | 1 |
| Fisher, JS; Lipsitz, JR; Minteer, SD; Patil, PB; Smith, JL | 1 |
| Borman, JB; Houminer, E; Khaliulin, I; Schneider, A; Schwalb, H | 1 |
| Deuschl, G; Raethjen, J | 1 |
| Afkhami, A; Madrakian, T; Mohammadnejad, M | 1 |
| Buck, K; Ferger, B | 1 |
| Barnum, CJ; Bhide, N; Bishop, C; Goldenberg, AA; Klioueva, A; Lindenbach, D; Surrena, MA; Tignor, S; Walters, H | 1 |
| Akdeniz, M; Yaman, A; Yaman, H | 1 |
| Fitzgerald, PJ; Maren, S; Seemann, JR | 1 |
| Macedo, CR; Macedo, EC; Prado, GF; Silva, AB; Torloni, MR | 1 |
| Barnum, CJ; Bhide, N; Bishop, C; George, JA; Lindenbach, D; Surrena, MA | 1 |
9 review(s) available for levodopa and propranolol
| Article | Year |
|---|---|
When symptoms persist: choosing among alternative somatic treatments for schizophrenia.
Topics: Anti-Anxiety Agents; Antipsychotic Agents; Benzodiazepines; Carbamazepine; Clozapine; Double-Blind Method; Electroconvulsive Therapy; Humans; Levodopa; Lithium; Propranolol; Reserpine; Schizophrenia | 1991 |
Disorders of prolactin and growth hormone secretion.
Topics: Acromegaly; Arginine; Clonidine; Dwarfism; Female; Glucose Tolerance Test; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Hypothalamo-Hypophyseal System; Hypothyroidism; Insulin-Like Growth Factor I; Kidney Failure, Chronic; Lactation; Levodopa; Male; Methyldopa; Physical Exertion; Pituitary Neoplasms; Pregnancy; Prolactin; Propranolol; Reserpine; Sleep; Somatomedins; Thyrotropin-Releasing Hormone | 1985 |
Catecholaminergic control of gonadotropin and prolactin secretion with particular reference to the possible participation of dopamine.
Topics: Animals; Brain Mapping; Castration; Dihydroxyphenylalanine; Dopamine; Drug Interactions; Electric Stimulation; Epinephrine; Estrogens; Female; Fenclonine; Follicle Stimulating Hormone; Gonadotropins, Pituitary; Haloperidol; Hypothalamus; In Vitro Techniques; Levodopa; Luteinizing Hormone; Male; Norepinephrine; Pargyline; Phenoxybenzamine; Pimozide; Progesterone; Prolactin; Propranolol; Rats; Serine; Synaptic Transmission; Thiocarbamates; Thyrotropin-Releasing Hormone; Time Factors | 1974 |
[New directions in contemporary pharmacotherapy of parkinsonism (review)].
Topics: Adrenergic beta-Antagonists; Anti-Anxiety Agents; Antiparkinson Agents; Apomorphine; Aromatic Amino Acid Decarboxylase Inhibitors; Bromocriptine; Drug Therapy, Combination; gamma-Aminobutyric Acid; Humans; Levodopa; Lisuride; Oxprenolol; Parkinson Disease; Piracetam; Piribedil; Propranolol | 1984 |
Medical treatment of later-stage motor problems of Parkinson disease.
Topics: Amantadine; Antiparkinson Agents; Benzophenones; Carbidopa; Catechol O-Methyltransferase Inhibitors; Catechols; Cholinergic Antagonists; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Combinations; Dyskinesia, Drug-Induced; Enzyme Inhibitors; Humans; Levodopa; Nitriles; Nitrophenols; Parkinson Disease, Secondary; Propranolol; Randomized Controlled Trials as Topic; Selegiline; Tolcapone | 1999 |
[Tremor].
Topics: Adrenergic beta-Antagonists; Anticonvulsants; Antiparkinson Agents; Botulinum Toxins; Cholinergic Agents; Diagnosis, Differential; Dopamine Agents; Drug Therapy, Combination; Humans; Levodopa; Magnetic Resonance Imaging; Parkinson Disease; Patient Compliance; Primidone; Propranolol; Radionuclide Imaging; Time Factors; Tremor | 2007 |
How best to address these common movement disorders.
Topics: Adrenergic beta-Antagonists; Adrenergic Uptake Inhibitors; Anticonvulsants; Antiparkinson Agents; Essential Tremor; Humans; Levodopa; Monoamine Oxidase Inhibitors; Movement Disorders; Parkinson Disease; Practice Guidelines as Topic; Primidone; Propranolol; Tetrabenazine; Tourette Syndrome; Treatment Outcome | 2011 |
Can fear extinction be enhanced? A review of pharmacological and behavioral findings.
Topics: Animals; Conditioning, Classical; Extinction, Psychological; Fear; Fluoxetine; Humans; Levodopa; Neurotransmitter Agents; Propranolol; Yohimbine | 2014 |
Pharmacotherapy for sleep bruxism.
Topics: Amitriptyline; Bromocriptine; Clonidine; Humans; Levodopa; Propranolol; Randomized Controlled Trials as Topic; Sleep Bruxism; Tryptophan | 2014 |
9 trial(s) available for levodopa and propranolol
| Article | Year |
|---|---|
Extended recombinant human growth hormone treatment after renal transplantation in children.
Topics: Adolescent; Adrenal Cortex Hormones; Age Determination by Skeleton; Anthropometry; Child; Female; Growth Disorders; Growth Hormone; Humans; Kidney Failure, Chronic; Kidney Function Tests; Kidney Transplantation; Levodopa; Male; Postoperative Complications; Propranolol; Puberty; Recombinant Proteins | 1992 |
The influence of adrenoreactive preparations on clinical and haemodynamic parameters in patients with ischaemic heart disease.
Topics: Adult; Angina Pectoris; Coronary Artery Disease; Coronary Disease; Double-Blind Method; Exercise Test; Hemodynamics; Humans; Levodopa; Middle Aged; Nonachlazine; Oxprenolol; Prazosin; Propranolol; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta | 1991 |
When symptoms persist: choosing among alternative somatic treatments for schizophrenia.
Topics: Anti-Anxiety Agents; Antipsychotic Agents; Benzodiazepines; Carbamazepine; Clozapine; Double-Blind Method; Electroconvulsive Therapy; Humans; Levodopa; Lithium; Propranolol; Reserpine; Schizophrenia | 1991 |
The effect of neuroleptics and other psychotropic drugs on negative symptoms in schizophrenia.
Topics: Alprazolam; Antipsychotic Agents; Chronic Disease; Clinical Trials as Topic; Dextroamphetamine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Humans; Levodopa; Propranolol; Psychiatric Status Rating Scales; Psychotropic Drugs; Schizophrenia; Schizophrenic Psychology | 1986 |
Adjuvant therapy of parkinsonian tremor.
Topics: Aged; Antiparkinson Agents; Carbidopa; Clonazepam; Double-Blind Method; Drug Therapy, Combination; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Primidone; Propranolol; Random Allocation; Tremor; Trihexyphenidyl | 1987 |
Pretreatment with somatostatin analog SMS 201-995 potentiates growth hormone (GH) responsiveness to GH-releasing factor in short children.
Topics: Adolescent; Arginine; Blood Glucose; Child; Drug Synergism; Female; Growth Disorders; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Insulin; Kinetics; Levodopa; Male; Octreotide; Propranolol | 1993 |
'Atypical' tremor.
Topics: Benserazide; Child; Child, Preschool; Cross-Over Studies; Double-Blind Method; Drug Combinations; Electromyography; Female; Humans; Infant; Levodopa; Male; Parkinson Disease; Propranolol; Tremor | 1995 |
Improvement of levodopa-induced dyskinesia by propranolol in Parkinson's disease.
Topics: Adrenergic beta-Antagonists; Adult; Antiparkinson Agents; Female; Humans; Levodopa; Male; Movement Disorders; Parkinson Disease; Propranolol; Prospective Studies; Treatment Outcome | 1996 |
Postural tremor of Parkinson's disease.
Topics: Adult; Aged; Antiparkinson Agents; Benserazide; Electromyography; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Propranolol; Tremor | 1994 |
107 other study(ies) available for levodopa and propranolol
| Article | Year |
|---|---|
Extrapolation of human pharmacokinetic parameters from rat, dog, and monkey data: Molecular properties associated with extrapolative success or failure.
Topics: Algorithms; Animals; Dogs; Haplorhini; Humans; Pharmaceutical Preparations; Pharmacokinetics; Rats; Species Specificity; Tissue Distribution | 2005 |
Transdermal penetration behaviour of drugs: CART-clustering, QSPR and selection of model compounds.
Topics: Anti-Inflammatory Agents; Cell Membrane Permeability; Cluster Analysis; Drug Evaluation, Preclinical; Humans; Models, Biological; Predictive Value of Tests; Quantitative Structure-Activity Relationship; Regression Analysis; Skin; Skin Absorption | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Toward an optimal blood-brain barrier shuttle by synthesis and evaluation of peptide libraries.
Topics: Biological Transport; Blood-Brain Barrier; Cell Survival; Drug Carriers; Humans; Levodopa; Membranes, Artificial; Peptide Library; Peptides; Permeability; Phenylalanine; Solubility | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
How well can the Caco-2/Madin-Darby canine kidney models predict effective human jejunal permeability?
Topics: Animals; Disease Models, Animal; Dogs; Humans; Jejunal Diseases; Kidney Diseases; Models, Biological; Permeability; Porosity; Regression Analysis | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Predicting phenolic acid absorption in Caco-2 cells: a theoretical permeability model and mechanistic study.
Topics: Artificial Intelligence; Caco-2 Cells; Cell Membrane Permeability; Cinnamates; Enterocytes; Humans; Hydrophobic and Hydrophilic Interactions; Intestinal Absorption; Kinetics; Models, Biological; Molecular Conformation; Osmolar Concentration; Phenols | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Physiological and pharmacological aids in the differential diagnosis of tremor.
Topics: Ataxia; Diagnosis, Differential; Ethanol; Humans; Isoproterenol; Levodopa; Methods; Parkinson Disease; Phenothiazines; Polyneuropathies; Propranolol; Tremor | 1976 |
[Therapy of Parkinson's disease. Practical criteria of treatment].
Topics: Amantadine; Antiparkinson Agents; Benserazide; Carbidopa; Cyproheptadine; Drug Therapy, Combination; Histamine H1 Antagonists; Humans; Levodopa; Parasympatholytics; Parkinson Disease; Piribedil; Pizotyline; Propranolol | 1976 |
The effect of adrenergic and ganglionic blockers upon the L-dopa-stimulated release of glucagon in the rat.
Topics: Animals; Dopamine; Ganglionic Blockers; Glucagon; Levodopa; Male; Pentolinium Tartrate; Phentolamine; Propranolol; Rats; Sympatholytics | 1978 |
Immunoreactive somatostatin in the hypothalamus and other regions of the rat brain: effects of insulin, glucose, alpha- or beta-blocker and L-dopa.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Brain Chemistry; Glucose; Growth Hormone; Hypothalamus; Insulin; Levodopa; Male; Phentolamine; Prolactin; Propranolol; Rats; Somatostatin | 1979 |
Involvement of biogenic amines in drug-induced aggressive pecking in chicks.
Topics: Aggression; Animals; Animals, Newborn; Antidepressive Agents; Biogenic Amines; Chickens; Dextroamphetamine; Dopamine; Female; Fenclonine; Haloperidol; Humans; Imipramine; Iprindole; Levodopa; Male; Methysergide; Pargyline; Phentolamine; Propranolol; Serotonin | 1975 |
Light and drug induced changes of epiphysial synaptic ribbons.
Topics: Animals; Fenclonine; Guinea Pigs; Levodopa; Light; Male; Norepinephrine; Pineal Gland; Propranolol; Reserpine; Sympathetic Nervous System; Synapses | 1976 |
Stimulation of growth hormone secretion by levodopa-propranolol in children and adolescents.
Topics: Adolescent; Age Determination by Skeleton; Arginine; Blood Glucose; Body Height; Child; Child, Preschool; Drug Therapy, Combination; Glucose Tolerance Test; Growth Hormone; Humans; Insulin; Levodopa; Propranolol | 1975 |
Cyclic adenosinemonophosphate in cerebrospinal fluid. Effects of theophylline, L-dopa and a dopamine receptor stimulant in rats.
Topics: Animals; Bis(4-Methyl-1-Homopiperazinylthiocarbonyl)disulfide; Cyclic AMP; Dose-Response Relationship, Drug; Levodopa; Male; Papaverine; Phentolamine; Piperazines; Piribedil; Propranolol; Rats; Receptors, Drug; Stimulation, Chemical; Time Factors | 1975 |
Adrenocortical responses of rats to acute hypoxic and hypercapnic stresses after treatment with aminergic agents.
Topics: Adrenal Cortex; Adrenal Glands; Adrenocorticotropic Hormone; Animals; Biogenic Amines; Bis(4-Methyl-1-Homopiperazinylthiocarbonyl)disulfide; Corticosterone; Dexamethasone; Fenclonine; Hypercapnia; Hypoxia; Levodopa; Male; Methyltyrosines; Pargyline; Phentolamine; Phenyl Ethers; Propranolol; Propylamines; Rats; Reserpine | 1976 |
[Effects of levodopa and piribedil on cyclic AMP levels in cerebrospinal fluid in rats (author's transl)].
Topics: Animals; Bis(4-Methyl-1-Homopiperazinylthiocarbonyl)disulfide; Brain; Cyclic AMP; Dopamine; Levodopa; Male; Phentolamine; Piperazines; Piribedil; Propranolol; Rats | 1976 |
beta-Adrenoceptor stimulation of exocrine secretion from the rat pancreas.
Topics: Acetylcholine; Animals; Atropine; Catecholamines; Dopamine; Haloperidol; Isoproterenol; Levodopa; Male; Myocardial Contraction; Pancreas; Phenoxybenzamine; Propranolol; Rats; Receptors, Adrenergic; Receptors, Adrenergic, beta; Secretin; Spinal Cord; Sympathomimetics; Vagotomy | 1978 |
The effect of psychotropic drugs on the TSH-response to thyroliberin (TRH).
Topics: Chlorpromazine; Fusaric Acid; Humans; Levodopa; Norepinephrine; Pimozide; Pituitary Gland, Anterior; Propranolol; Psychotropic Drugs; Receptors, Adrenergic; Receptors, Adrenergic, alpha; Thioridazine; Thyrotropin; Thyrotropin-Releasing Hormone | 1977 |
The effect of L-dopa and propranolol on human CSF cyclic nucleotides.
Topics: Adult; Aged; Cyclic AMP; Cyclic GMP; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Propranolol; Schizophrenia | 1978 |
Behavioral side effects of medical drugs.
Topics: Adrenal Cortex Hormones; Aged; Antihypertensive Agents; Antitubercular Agents; Aspirin; Behavior; Caffeine; Cimetidine; Contraceptives, Oral, Hormonal; Digitalis Glycosides; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Levodopa; Male; Mental Disorders; Parasympatholytics; Placebos; Propranolol; Psychoses, Substance-Induced; Reserpine; Sympathomimetics; Thyroid Hormones | 1979 |
[Fluorogenic amines in the notochords of chick embryos treated by cholinergics].
Topics: Animals; Atropine; Biogenic Amines; Carbachol; Chick Embryo; Levodopa; Microscopy, Fluorescence; Nicotine; Norepinephrine; Parasympathomimetics; Propranolol; Reserpine; Spine | 1977 |
Combined oral L-dopa and propranolol for growth hormone provocation.
Topics: Child; Growth Hormone; Humans; Hydrocortisone; Hypoglycemia; Insulin; Levodopa; Propranolol | 1979 |
Relative usefulness of three growth hormone stimulation screening tests.
Topics: Child; False Positive Reactions; Growth Disorders; Growth Hormone; Humans; Levodopa; Propranolol; Sleep | 1979 |
Role of peripheral adrenoreceptors and vasopressin in the suppression of plasma renin activity by L-dopa in carbidopa-treated dogs.
Topics: Animals; Carbidopa; Dogs; Drug Interactions; Female; Levodopa; Male; Phenoxybenzamine; Propranolol; Receptors, Adrenergic; Renin; Vasopressins | 1979 |
Role of dopaminergic and noradrenergic mechanisms in Metrazole convulsions in mice.
Topics: Animals; Apomorphine; Benserazide; Bis(4-Methyl-1-Homopiperazinylthiocarbonyl)disulfide; Clonidine; Dopamine; Drug Interactions; Female; Haloperidol; Levodopa; Male; Methyltyrosines; Mice; Norepinephrine; Pentylenetetrazole; Phenoxybenzamine; Propranolol; Receptors, Dopamine; Reserpine; Seizures; Tetrabenazine | 1979 |
Effect of adrenergic stimulation and blockade on melatonin secretion in the human.
Topics: Adult; Circadian Rhythm; Humans; Levodopa; Male; Melatonin; Metaproterenol; Pineal Gland; Propranolol; Seasons | 1979 |
Effects of alpha- and beta-adrenergic blocking agents on serum prolactin levels in women with hyperprolactinemia and galactorrhea.
Topics: Adenoma; Adult; Female; Galactorrhea; Humans; Lactation Disorders; Levodopa; Phentolamine; Pituitary Neoplasms; Pregnancy; Prolactin; Propranolol | 1977 |
Growth hormone response to propranolol and L--dopa in obese subjects.
Topics: Adolescent; Adult; Female; Growth Hormone; Humans; Kinetics; Levodopa; Male; Middle Aged; Obesity; Placebos; Propranolol | 1978 |
Reevaluation of levodopa-propranolol as a test of growth hormone reserve in children.
Topics: Adolescent; Arginine; Child; Female; Growth; Growth Hormone; Humans; Insulin; Levodopa; Male; Propranolol | 1978 |
On the mechanism of hyperglycemia and stimulation of growth hormone secretion by L-dopa.
Topics: Animals; Blood Glucose; Carbidopa; Dogs; Glucose; Growth Hormone; Hydrocortisone; Levodopa; Liver; Phentolamine; Pimozide; Propranolol; Stress, Physiological; Time Factors | 1978 |
The effects of putative 5-hydroxytryptamine antagonists on the behaviour produced by administration of tranylcypromine and L-tryptophan or tranylcypromine and L-DOPA to rats.
Topics: Animals; Behavior, Animal; Brain; Drug Interactions; Levodopa; Male; Methyltyrosines; p-Chloroamphetamine; Propranolol; Rats; Serotonin; Serotonin Antagonists; Spinal Cord; Tranylcypromine; Tryptamines; Tryptophan | 1978 |
The shaking patient. Diagnosis and management of tremor.
Topics: Amantadine; Carbidopa; Cerebellar Diseases; Humans; Levodopa; Parkinson Disease; Propranolol; Tremor | 1977 |
Adrenergic modulation of growth hormone secretion in acromegaly: alpha- and beta-adrenergic blockade produce qualitatively normal responses but no effect on L-dopa suppresion.
Topics: Acromegaly; Adult; Female; Growth Hormone; Humans; Levodopa; Male; Middle Aged; Phentolamine; Propranolol | 1977 |
Possible complications of the levodopa-propranolol test.
Topics: Child; Child, Preschool; Growth Hormone; Humans; Levodopa; Male; Propranolol | 1977 |
[Studies on the effects of simultaneous administrations of propranolol and glucagon on the release of growth hormone (author's transl)].
Topics: Adolescent; Adult; Arginine; Blood Glucose; Fatty Acids, Nonesterified; Female; Glucagon; Growth Hormone; Humans; Hydrocortisone; Insulin; Levodopa; Male; Pituitary Diseases; Pituitary Function Tests; Propranolol; Stimulation, Chemical | 1977 |
[Nervous regulation of pituitary somatotropin secretion].
Topics: Animals; Brain Mapping; Dopamine; Electrophysiology; Feedback; Glucose; Growth Hormone; Homeostasis; Hypothalamus; Levodopa; Limbic System; Norepinephrine; Phentolamine; Pituitary Gland, Anterior; Propranolol; Rats; Receptors, Drug; Serotonin | 1977 |
The action of microelectrophoretically applied L-3,4-dihydroxyphenylalanine (DOPA) on single cortical neurones.
Topics: Acetylcholine; Action Potentials; Animals; Atropine; Cats; Cerebral Cortex; Electrophoresis; Female; Levodopa; Male; Microchemistry; Neurons; Norepinephrine; Phentolamine; Propranolol; Rats; Time Factors | 1976 |
[Attempt at potentiation of the action of L-dopa on the secretion of growth hormone by benserazide, disulfiram and propranolol].
Topics: Adolescent; Benserazide; Child; Disulfiram; Drug Synergism; Growth Hormone; Humans; Hydrazines; Levodopa; Male; Propranolol | 1976 |
Reinstatement of vaginal cycles in aged female rats.
Topics: Aging; Animals; Benserazide; Carbidopa; Dose-Response Relationship, Drug; Drug Interactions; Estrus; Female; Fusaric Acid; Hypophysectomy; Levodopa; Phenoxybenzamine; Pimozide; Pregnancy; Propranolol; Rats; Tyrosine; Vagina | 1976 |
Levodopa-induced myoclonus.
Topics: 5-Hydroxytryptophan; Aged; Amantadine; Amphetamine; Animals; Benztropine; Dopamine Antagonists; Dose-Response Relationship, Drug; Female; Guinea Pigs; Humans; Levodopa; Male; Methysergide; Middle Aged; Movement Disorders; Myoclonus; Parkinson Disease; Propranolol; Serotonin; Serotonin Antagonists; Sleep; Trihexyphenidyl | 1975 |
Persistent parkinsonism following neuroleptanalgesia.
Topics: Adolescent; Anesthesia, Inhalation; Anesthesia, Intravenous; Droperidol; Female; Fentanyl; Humans; Levodopa; Neuroleptanalgesia; Nitrous Oxide; Parkinson Disease; Parkinson Disease, Secondary; Propranolol; Tooth Extraction; Tooth, Impacted | 1975 |
Dopaminergic control of growth hormone secretion in normal and acromegalic subjects.
Topics: Acromegaly; Amantadine; Bromocriptine; Ergolines; Growth Hormone; Humans; Hypothalamo-Hypophyseal System; Levodopa; Phentolamine; Pituitary Gland; Propranolol | 1975 |
[Effect of L-dopa and propranolol administration on GH secretion in essential obesity in women].
Topics: Administration, Oral; Adult; Aged; Female; Growth Hormone; Humans; Injections, Intravenous; Levodopa; Male; Middle Aged; Obesity; Pituitary Gland; Pituitary Gland, Anterior; Propranolol; Stimulation, Chemical | 1975 |
[Slow leg tremor].
Topics: Adult; Aged; Alcoholism; Follow-Up Studies; Humans; Leg; Levodopa; Male; Middle Aged; Propranolol; Tremor | 1975 |
Augmenting procedures during L-dopa therapy for Parkinsonism.
Topics: Antacids; Dextroamphetamine; Drug Synergism; Female; Humans; Imipramine; Levodopa; Male; Middle Aged; Parkinson Disease; Propranolol | 1975 |
Propranolol-augmented, exercise-induced human growth hormone release.
Topics: Administration, Oral; Adolescent; Adult; Arginine; Child; Child, Preschool; Female; Growth Hormone; Humans; Injections, Intravenous; Insulin; Levodopa; Male; Physical Exertion; Propranolol | 1975 |
Effects of environmental lighting, superior cervical ganglionectomy and adrenergic drugs on microtubule protein levels of the rat hypothalamus.
Topics: Animals; Autonomic Agents; Dactinomycin; Ganglia, Autonomic; Hypothalamus; Isoproterenol; Levodopa; Light; Male; Microtubules; Nerve Tissue Proteins; Neural Pathways; Norepinephrine; Phentolamine; Propranolol; Rats | 1975 |
[Effects of adrenergic blocking agents on HGH secretion after administration of L-Dopa].
Topics: Adolescent; Adult; Blood Glucose; Fatty Acids, Nonesterified; Growth Hormone; Humans; Levodopa; Middle Aged; Phentolamine; Pituitary Gland; Pituitary Gland, Anterior; Propranolol | 1975 |
[Role of brain biogenic amines in the central thermoregulatory mechanism of the rat (author's transl)].
Topics: Adaptation, Physiological; Animals; Biogenic Amines; Blood Glucose; Body Temperature Regulation; Cerebral Ventricles; Dopamine; Dose-Response Relationship, Drug; Fatty Acids, Nonesterified; Haloperidol; Hydroxydopamines; Hypothermia; Imipramine; Isoproterenol; Levodopa; Male; Norepinephrine; Oxygen Consumption; Phenoxybenzamine; Phenylephrine; Propranolol; Rats; Rectum; Serotonin; Skin Temperature | 1975 |
Centrally mediated increased reflex vagal bradycardia after L-dopa in monoamine oxidase-inhibited anesthetized dogs.
Topics: Animals; Atropine; Benserazide; Blood Pressure; Carbidopa; Dogs; Dopamine; Drug Interactions; Female; Levodopa; Male; Monoamine Oxidase Inhibitors; Norepinephrine; Phentolamine; Pressoreceptors; Propranolol; Vagus Nerve | 1976 |
Picomolar concentrations of L-dopa stereoselectively potentiate activities of presynaptic beta-adrenoceptors to facilitate the release of endogenous noradrenaline from rat hypothalamic slices.
Topics: Animals; Cocaine; Electric Stimulation; Hydrazines; Hypothalamus; In Vitro Techniques; Isoproterenol; Levodopa; Male; Norepinephrine; Propranolol; Rats; Rats, Inbred Strains; Receptors, Adrenergic, beta; Stereoisomerism | 1991 |
Growth hormone response in very short children.
Topics: Adolescent; Child; Circadian Rhythm; Diagnosis, Differential; Dwarfism, Pituitary; Exercise Test; Female; Growth Disorders; Growth Hormone; Humans; Levodopa; Male; Predictive Value of Tests; Propranolol; Puberty; Stimulation, Chemical | 1991 |
L-dihydroxyphenylalanine methyl ester is a potent competitive antagonist of the L-dihydroxyphenylalanine-induced facilitation of the evoked release of endogenous norepinephrine from rat hypothalamic slices.
Topics: Animals; Binding, Competitive; Carbidopa; Cocaine; Hydrazines; Hypothalamus; In Vitro Techniques; Levodopa; Norepinephrine; Propranolol; Rats; Structure-Activity Relationship; Sulpiride | 1991 |
L-dopa methyl ester antagonizes competitively L-dopa-induced facilitation of noradrenaline release from rat hypothalamic slices.
Topics: Animals; Binding, Competitive; Hypothalamus; In Vitro Techniques; Levodopa; Norepinephrine; Phenylalanine; Propranolol; Rats | 1990 |
[The diagnostic value of the propranolol-glucagon test for somatotropin secretion].
Topics: Acromegaly; Glucagon; Growth Hormone; Humans; Levodopa; Propranolol; Stimulation, Chemical; Time Factors | 1989 |
[3 cases of conservatively treated aortic dissecting aneurysm in patients with arterial hypertension. Results of a long-term ambulatory observation].
Topics: Aged; Ambulatory Care; Antihypertensive Agents; Aorta, Abdominal; Aortic Aneurysm; Aortic Dissection; Humans; Hypertension; Levodopa; Male; Middle Aged; Propranolol; Time Factors | 1988 |
Serum somatomedin activity and growth hormone level in obese men: dependence on degree of obesity and hyperlipidemia.
Topics: Adult; Body Weight; Growth Hormone; Humans; Hyperlipidemias; Levodopa; Male; Middle Aged; Obesity; Propranolol; Somatomedins | 1986 |
Transient growth hormone deficiency after treatment of primary hypothyroidism.
Topics: Adolescent; Glucagon; Growth Hormone; Humans; Hypopituitarism; Hypothyroidism; Levodopa; Male; Propranolol; Sleep | 1987 |
Biphasic actions of L-DOPA on the release of endogenous dopamine via presynaptic receptors in rat striatal slices.
Topics: Animals; Brocresine; Cocaine; Corpus Striatum; Dopamine; Drug Interactions; In Vitro Techniques; Levodopa; Male; Propranolol; Rats; Rats, Inbred Strains; Sulpiride | 1986 |
Combined resting-postural tremors.
Topics: Aged; Ethanol; Female; Humans; Levodopa; Male; Middle Aged; Posture; Propranolol; Rest; Tremor; Trihexyphenidyl | 1985 |
Letter: Enhancement of levodopa-induced growth-hormone stimulation by practolol.
Topics: Drug Synergism; Growth Hormone; Humans; Levodopa; Obesity; Practolol; Propranolol; Stimulation, Chemical | 1974 |
Drug treatment of diseases characterized by abnormal movements.
Topics: Chorea; Diazepam; Ethanol; Haloperidol; Humans; Huntington Disease; Levodopa; Movement Disorders; Myoclonus; Phenothiazines; Propranolol; Reserpine; Tetrabenazine; Tic Disorders; Torticollis; Tourette Syndrome; Tremor | 1973 |
L-dopa induced plasma glucagon release.
Topics: Animals; Blood Glucose; Dose-Response Relationship, Drug; Glucagon; Growth Hormone; Injections, Intravenous; Insulin; Levodopa; Macaca mulatta; Male; Phentolamine; Propranolol; Radioimmunoassay | 1974 |
Continuing studies of the peripheral vascular actions of dopamine.
Topics: Animals; Barium; Basilar Artery; Constriction; Coronary Vessels; Dilatation; Dogs; Dopamine; Femoral Artery; Heart; Levodopa; Mesenteric Arteries; Phenoxybenzamine; Propranolol; Prostaglandin Antagonists; Receptors, Drug; Renal Artery; Sotalol; Structure-Activity Relationship; Vasodilator Agents; Vasopressins | 1974 |
Propranolol enhancement of L-DOPA induced growth hormone stimulation.
Topics: Adolescent; Adult; Drug Synergism; Female; Growth Hormone; Humans; Injections, Intravenous; Levodopa; Male; Propranolol; Secretory Rate; Stimulation, Chemical | 1974 |
[Effect of L-DOPA, phentolamine, aminophylline and propranolol on growth hormone secretion in patients with normal anterior pituitary function and subjects with acromegaly].
Topics: Acromegaly; Aminophylline; Growth Hormone; Humans; Levodopa; Phentolamine; Pituitary Gland; Pituitary Gland, Anterior; Propranolol | 1974 |
[Relation between analgesic action and cyclic-AMP content in the rat brain after administration of several kinds of drugs].
Topics: Analgesics; Animals; Brain; Chlorpromazine; Cyclic AMP; Cyclic GMP; Female; Haloperidol; Levodopa; Lithium; Norepinephrine; Propranolol; Rats; Rats, Inbred Strains | 1984 |
[Pathogenetic therapy of cobalt-induced cardiomyopathies].
Topics: Adrenergic beta-Antagonists; Anabolic Agents; Animals; Cardiomyopathies; Cobalt; Drug Evaluation, Preclinical; Levodopa; Male; Nandrolone; Nandrolone Decanoate; Nialamide; Propranolol; Rats; Succinates; Sulfhydryl Compounds | 1980 |
The relative importance of dopamine and norepinephrine in mediating locomotor activity.
Topics: Adrenergic Antagonists; Amphetamines; Animals; Apomorphine; Biomechanical Phenomena; Brain Chemistry; Catecholamines; Clonidine; Corpus Striatum; Dopamine; Droxidopa; Isoproterenol; Levodopa; Limbic System; Locomotion; Neural Pathways; Neurotransmitter Agents; Norepinephrine; Nucleus Accumbens; Propranolol; Receptors, Dopamine; Reserpine; Serotonin; Serotonin Antagonists; Substantia Nigra; Tetrahydronaphthalenes | 1983 |
[Role of adrenergic receptors in the mechanism of action of catecholamines and DOPA on proliferative processes].
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Epinephrine; Isoproterenol; L Cells; Levodopa; Mice; Mitotic Index; Phenoxybenzamine; Propranolol; Receptors, Adrenergic | 1984 |
[Pharmacological analysis of the role of dorsal hippocampus adrenergic effects in the central mechanisms of ovulation and compensatory ovarian hypertrophy in rats].
Topics: Animals; Castration; Female; Hippocampus; Hypertrophy; Levodopa; Ovary; Ovulation; Phentolamine; Propranolol; Rats; Receptors, Adrenergic; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta | 1980 |
Superior cervical ganglionectomy depresses norepinephrine uptake, increases the density of alpha-adrenoceptor sites, and induces supersensitivity to adrenergic drugs in rat medial basal hypothalamus.
Topics: Animals; Dihydroalprenolol; Ganglia, Sympathetic; Hypothalamus; Isoproterenol; Kinetics; Levodopa; Male; Norepinephrine; Phentolamine; Propranolol; Rats; Rats, Inbred Strains; Receptors, Adrenergic; Receptors, Adrenergic, alpha; Tubulin | 1981 |
Depending on the stimulus, central serotoninergic activation by fenfluramine blocks or does not alter growth hormone secretion in man.
Topics: Adult; Animals; Arginine; Female; Fenfluramine; Growth Hormone; Humans; Hypothalamo-Hypophyseal System; Insulin; Levodopa; Male; Prolactin; Propranolol; Rats; Rats, Inbred Strains; Receptors, Serotonin; Serotonin | 1984 |
Comparison of single and combined tests for the evaluation of plasma growth hormone secretion in normal short children.
Topics: Adolescent; Body Height; Bromocriptine; Child; False Negative Reactions; Growth Hormone; Humans; Hypoglycemia; Insulin; Levodopa; Physical Exertion; Propranolol | 1984 |
Influence of levodopa, apomorphine and 3,4-dihydroxyphenylserine (DOPS) on strychnine-induced seizures in mice.
Topics: Animals; Apomorphine; Droxidopa; Levodopa; Mice; Phentolamine; Propranolol; Seizures; Serine; Strychnine | 1984 |
The pharmacology of olivopontocerebellar atrophy.
Topics: Adult; Amantadine; Atrophy; Baclofen; Brain Diseases; Carbidopa; Cerebellar Ataxia; Female; Humans; Levodopa; Male; Middle Aged; Olivary Nucleus; Pons; Propranolol; Syndrome | 1984 |
Mediator mechanisms of cathinone effects on animal behaviour.
Topics: Alkaloids; Animals; Biogenic Amines; Cats; Conditioning, Classical; Dopamine; Levodopa; Methysergide; Phentolamine; Propranolol; Serotonin; Sympathetic Nervous System | 1983 |
[The L-DOPA-propranolol test for the evaluation of reserves in secretory growth hormone].
Topics: Adolescent; Adult; Age Determination by Skeleton; Blood Glucose; Body Height; Child; Child, Preschool; Dwarfism; Growth Hormone; Humans; Infant; Levodopa; Propranolol; Stimulation, Chemical | 1983 |
[Evaluation of growth hormone stimulation tests using clonidine, glucagon, propanolol, hypoglycemia, arginine and L-dopa in 267 children of short stature].
Topics: Arginine; Child; Clonidine; Dwarfism; Glucagon; Growth Hormone; Humans; Hypoglycemia; Levodopa; Propranolol; Sleep; Stimulation, Chemical | 1984 |
Effects of Peripheral monoamines on the monosynaptic reflex neuronal activity of acute spinal cats.
Topics: Animals; Cats; Cordotomy; Dopamine; Dose-Response Relationship, Drug; Female; Haloperidol; Levodopa; Male; Motor Neurons; Norepinephrine; Pargyline; Phenoxybenzamine; Propranolol; Reflex, Monosynaptic | 1981 |
Dopaminergic modulation of renin release.
Topics: Animals; Blood Pressure; Dopamine; Dopamine Antagonists; Hypertension; Levodopa; Male; Metoclopramide; Phentolamine; Propranolol; Rats; Renin | 1981 |
The levodopa-propranolol test for growth hormone screening.
Topics: Child; Growth Hormone; Humans; Levodopa; Propranolol | 1982 |
Propranolol-induced hypoglycemia during growth hormone testing.
Topics: Blood Glucose; Child; Glucagon; Growth Hormone; Humans; Hypoglycemia; Hypopituitarism; Levodopa; Propranolol; Retrospective Studies | 1981 |
IgA deficiency associated with growth hormone deficiency in a boy with short arm deletion of chromosome 18 (46,XY,18p-).
Topics: Arginine; Child; Chromosome Aberrations; Chromosome Disorders; Chromosomes, Human, Pair 18; Developmental Disabilities; Dwarfism, Pituitary; Growth Hormone; Humans; IgA Deficiency; Insulin; Intellectual Disability; Levodopa; Male; Pituitary Function Tests; Propranolol; Sequence Deletion | 1994 |
Screening test for growth hormone deficiency: usefulness of L-dopa-propranolol provocative test.
Topics: Adolescent; Child; Child, Preschool; Female; Growth Disorders; Growth Hormone; Humans; Infant; Levodopa; Male; Mass Screening; Propranolol; Retrospective Studies | 1994 |
Use of everted intestinal rings for in vitro examination of oral absorption potential.
Topics: Administration, Oral; Animals; Dimethyl Sulfoxide; Duodenum; Ethanol; Hydrogen-Ion Concentration; Ileum; In Vitro Techniques; Intestinal Absorption; Intestinal Mucosa; Jejunum; Levodopa; Male; Models, Biological; Pharmacokinetics; Polyethylene Glycols; Predictive Value of Tests; Propranolol; Rats; Rats, Sprague-Dawley | 1994 |
Growth hormone and IGF1 profile in short children with osteopetrosis.
Topics: Adolescent; Age Determination by Skeleton; Blood Glucose; Body Height; Child; Child, Preschool; Female; Growth Hormone; Humans; Insulin; Insulin-Like Growth Factor I; Levodopa; Male; Osteopetrosis; Propranolol; Saudi Arabia | 1994 |
[Statistic study of 5,473 somatotropin secretion stimulation pharmacologic tests (n=9). Proposed weighting coefficient].
Topics: Adolescent; Age Determination by Skeleton; Arginine; Betaxolol; Child; Child, Preschool; Clonidine; Confidence Intervals; Data Interpretation, Statistical; Female; Glucagon; Growth Disorders; Growth Hormone; Humans; Insulin; Levodopa; Male; Normal Distribution; Ornithine; Propranolol; Puberty; Radioimmunoassay; Retrospective Studies; Sensitivity and Specificity | 1993 |
Inclusion body myositis associated with a severe unilateral levodopa-responsive upper extremity tremor.
Topics: Action Potentials; Anti-Dyskinesia Agents; Brain Neoplasms; Electromyography; Hand; Humans; Inclusion Bodies; Levodopa; Lipoma; Magnetic Resonance Imaging; Male; Microscopy, Electron; Middle Aged; Muscle, Skeletal; Myositis, Inclusion Body; Propranolol; Tremor; Trihexyphenidyl; Vacuoles | 1996 |
Midbrain tremor and hypertrophic olivary degeneration after pontine hemorrhage.
Topics: Adrenergic beta-Antagonists; Anticonvulsants; Antiparkinson Agents; Cerebral Hemorrhage; Clonazepam; Electric Stimulation; Electrodes, Implanted; Humans; Hypertrophy; Levodopa; Magnetic Resonance Imaging; Male; Mesencephalon; Middle Aged; Nerve Degeneration; Neural Pathways; Olivary Nucleus; Pons; Propranolol; Thalamus; Tremor | 1997 |
Simultaneous stimulation of growth hormone, adrenocorticotropin and cortisol with L-dopa/L-carbidopa and propranolol in children of short stature.
Topics: Adolescent; Adrenocorticotropic Hormone; Carbidopa; Child; Child, Preschool; Dopamine Agents; Drug Synergism; Female; Growth Disorders; Growth Hormone; Humans; Hydrocortisone; Levodopa; Male; Pituitary Function Tests; Propranolol | 2000 |
Essential tremor course and disability: A clinicopathologic study of 20 cases.
Topics: Adrenergic beta-Antagonists; Age of Onset; Aged; Antiparkinson Agents; Disability Evaluation; Disease Progression; Essential Tremor; Female; Humans; Levodopa; Lewy Body Disease; Male; Propranolol; Saskatchewan; Supranuclear Palsy, Progressive | 2004 |
Possibility of autocrine beta-adrenergic signaling in C2C12 myotubes.
Topics: Adrenergic beta-Antagonists; Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Autocrine Communication; Biological Transport, Active; Cell Line; Cyclic AMP; Dopa Decarboxylase; Dopamine; Dopamine Agents; Glucose; Hydrazines; Hypoglycemic Agents; Insulin; Levodopa; Mice; Muscle Fibers, Skeletal; Muscle, Skeletal; Myoblasts, Skeletal; Propranolol | 2005 |
Apomorphine-induced myocardial protection is due to antioxidant and not adrenergic/dopaminergic effects.
Topics: Adrenergic Agents; Animals; Antioxidants; Apomorphine; Dopamine Agents; Electrophoresis, Polyacrylamide Gel; Haloperidol; Heart; Hemodynamics; Immunoblotting; Levodopa; Male; Myocardial Reperfusion Injury; Propranolol; Rats; Rats, Sprague-Dawley | 2006 |
Simultaneous spectrofluorimetric determination of levodopa and propranolol in urine using feed-forward neural networks assisted by principal component analysis.
Topics: Fresh Water; Hydrogen-Ion Concentration; Levodopa; Neural Networks, Computer; Principal Component Analysis; Propranolol; Sodium Dodecyl Sulfate; Spectrometry, Fluorescence | 2009 |
The selective alpha1 adrenoceptor antagonist HEAT reduces L-DOPA-induced dyskinesia in a rat model of Parkinson's disease.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Antiparkinson Agents; Brain; Cerebrospinal Fluid; Disease Models, Animal; Dyskinesia, Drug-Induced; Idazoxan; Levodopa; Male; Motor Activity; Oxidopamine; Parkinsonian Disorders; Plasma; Propranolol; Random Allocation; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-1; Tetralones | 2010 |
Effects of noradrenergic denervation on L-DOPA-induced dyskinesia and its treatment by α- and β-adrenergic receptor antagonists in hemiparkinsonian rats.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adrenergic Neurons; Animals; Behavior, Animal; Corpus Striatum; Desipramine; Disease Models, Animal; Dyskinesia, Drug-Induced; Hippocampus; Idazoxan; Levodopa; Male; Molecular Targeted Therapy; Neuroprotective Agents; Oxidopamine; Parkinson Disease; Propranolol; Rats; Rats, Sprague-Dawley; Severity of Illness Index; Sympathectomy, Chemical | 2012 |
Effects of the beta-adrenergic receptor antagonist Propranolol on dyskinesia and L-DOPA-induced striatal DA efflux in the hemi-parkinsonian rat.
Topics: Adrenergic beta-Antagonists; Animals; Antiparkinson Agents; Chromatography, High Pressure Liquid; Corpus Striatum; Dopamine; Dyskinesia, Drug-Induced; Levodopa; Male; Microdialysis; Motor Activity; Parkinsonian Disorders; Propranolol; Rats; Rats, Sprague-Dawley | 2015 |